Neuroprotective Studies of Evodiamine in an Okadaic Acid-Induced Neurotoxicity.

Published in: International journal of molecular sciences (2021)

Evodiamine can decrease the neurotoxicity of tau aggregation and exhibit a neuroprotective effect. Our results demonstrate that evodiamine has a therapeutic potential for AD treatment.

Keyphrases

cerebral ischemia
case control
blood brain barrier
combination therapy